Some gallbladder problems require surgery
9 58% of patients stop taking GLP-1s before seeing a clinically meaningful health benefit 10 We have to be cautious with GLP-1s, as were still learning where they are most effective and what the long-term side effects are, explains Dr

Disclosures: Bima Hasjim: Nothing to Disclose, Anjana Rajan: Nothing to Disclose, Nivetha Saravanan: Nothing to Disclose, Katherine Cooper: Nothing to Disclose, Deepika Devuni: Nothing to Disclose, Kawthar Mohamed: Nothing to Disclose, Nicholas Lim: Nothing to Disclose, Allison Kwong: Nothing to Disclose, Weiyu Wu: Nothing to Disclose, Kaleb Tesfai: Nothing to Disclose, Veeral Ajmera: Nothing to Disclose, Kevin Wang: Nothing to Disclose, Hersh Shroff: Nothing to Disclose, Amanda Cheung: Nothing to Disclose 930 ELEVATED RATES OF LIVER AND INTRAHEPATIC DUCT CANCER IN NATIVE AMERICAN AND ALASKAN NATIVE FEMALES VERSUS MALES WHEN COMPARED TO THEIR WHITE COUNTERPARTS: A 5-YEAR REGIONAL ANALYSIS Tulika Saggar 1 Atul Sinha 1 James Pellegrini 1 Ana Rivera 1 Paul Mustacchia 1 , 1 Nassau University Medical Center Background: Liver and intrahepatic duct cancers are a leading cause of cancer deaths worldwide with over 700,000 deaths yearly

An interesting study also showed that oral administration of GLP-1 could reduce depression risk caused by hyperglycemia in a patient with type 2 diabetes (Onoviran et al., 2019)
Abdominal ultrasonography and MRI did not reveal any signs of biliary obstruction or gallstones (Figs.1 and 2)